Your browser doesn't support javascript.
loading
Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma.
Lu, Hanwen; Zhang, Bingchang; Xie, Yuanyuan; Zhao, Wenpeng; Han, Wanhong; Zhou, Liwei; Wang, Zhanxiang.
Afiliação
  • Lu H; The Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen City, China.
  • Zhang B; Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen City, China.
  • Xie Y; The Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen City, China.
  • Zhao W; Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen City, China.
  • Han W; The Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen City, China.
  • Zhou L; Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen City, China.
  • Wang Z; The Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen City, China.
Invest New Drugs ; 41(4): 564-578, 2023 08.
Article em En | MEDLINE | ID: mdl-37322389
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China